Artificial Intelligence is all around us, accelerating medical drug development, selecting what content we see across social media or outclassing us on the most human of tasks from driving to medical diagnoses. The transformational power of AI has the potential to alter our society as profoundly as the agricultural and industrial revolutions, but how did we get here?
What is intelligence, and why do we seek to replicate it artificially?
When did the AI revolution begin, and can you recall your first encounter with AI?
21 Nov. 2023
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Graduate Studies Office Coordinator to join our team at the Champalimaud Research Programme. Since the beginning, Champalimaud Research has regarded educating future scientists as one of its main objectives. To this end, the CR has been dedicating considerable efforts to the development and implementation of outstanding educational programmes, including world-class Ph.D.
20 November 2023
If a teacup is steaming, you’ll wait a bit longer before drinking from it. And if your fingers get caught in the door, you'll be more careful next time. These are forms of associative learning, where a positive or negative experience leads to learning behavior. We know that our cerebellum is important in this form of learning. But how exactly does this work?
On behalf of the Champalimaud Research Programme on Digital Therapeutics led by Dr. John Krakauer and Dr. Joe Paton, we'd like to invite you to the workshop on interactive AI systems. At Digital Therapeutics group, our mission is to leverage cutting-edge technology to create evidence-based, personalised medical interventions to prevent, manage, or treat a broad spectrum of physical, mental, and behavioural conditions.
02 November 2023
In this audio interview, Gonçalo explains how this grant will fund ongoing work on Lesional Obsessive Compulsive Disorder (OCD) that is being developed in collaboration with several members of the Neuropsychiatry Unit. The proposal is to use the results from this work to test a new treatment for OCD through transcranial magnetic stimulation (TMS), which will include the Neuropsychiatry Unit’s first clinical trial using therapeutic TMS.
Listen to the full audio recording to find out more!